Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-074301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-16 | SNDX | Botwood Nicholas A.J. | CMO, Head of R, D | P - Purchase | $9.00 | +11.8K | 35.2K | +50% | +$105.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | P | A | 11,765 | $9.00 | 35,165 | D | — | — |